Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer.
作者信息
Kim Hyung Jin, Oh Seong Taek
机构信息
Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Ann Coloproctol. 2016 Apr;32(2):47-8. doi: 10.3393/ac.2016.32.2.47. Epub 2016 Apr 30.
Abstract
摘要
相似文献
1
Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer.
Ann Coloproctol. 2016 Apr;32(2):47-8. doi: 10.3393/ac.2016.32.2.47. Epub 2016 Apr 30.
2
Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer.
Ann Coloproctol. 2016 Apr;32(2):66-72. doi: 10.3393/ac.2016.32.2.66. Epub 2016 Apr 30.
3
Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer.
Cancer. 2016 Aug 1;122(15):2341-9. doi: 10.1002/cncr.30049. Epub 2016 May 18.
4
Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
PLoS One. 2017 Oct 12;12(10):e0186341. doi: 10.1371/journal.pone.0186341. eCollection 2017.
5
Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients.
Brachytherapy. 2014 Jan-Feb;13(1):59-67. doi: 10.1016/j.brachy.2013.05.004. Epub 2013 Jul 18.
6
Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.
JAMA Oncol. 2015 Oct;1(7):897-906. doi: 10.1001/jamaoncol.2015.2316.
7
Prospective evaluation of urinary and intestinal side effects after BeamCath stereotactic dose-escalated radiotherapy of prostate cancer.
Radiother Oncol. 2002 Jun;63(3):239-48. doi: 10.1016/s0167-8140(02)00107-x.
8
Variations in patterns of concurrent androgen deprivation therapy use based on dose escalation with external beam radiotherapy vs. brachytherapy boost for prostate cancer.
Brachytherapy. 2019 May-Jun;18(3):322-331. doi: 10.1016/j.brachy.2019.01.016. Epub 2019 Mar 9.
9
Controversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature.
Prostate. 2010 May 15;70(7):701-9. doi: 10.1002/pros.21102.
10
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.
J Clin Oncol. 2011 Nov 10;29(32):4234-42. doi: 10.1200/JCO.2010.33.9549. Epub 2011 Oct 11.
本文引用的文献
1
Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer.
Ann Coloproctol. 2016 Apr;32(2):66-72. doi: 10.3393/ac.2016.32.2.66. Epub 2016 Apr 30.
2
Reirradiation of locally recurrent rectal cancer: a systematic review.
Radiother Oncol. 2014 Nov;113(2):151-7. doi: 10.1016/j.radonc.2014.11.021. Epub 2014 Nov 26.
3
Management of recurrent rectal cancer: practical insights in planning and surgical intervention.
J Surg Oncol. 2014 Jan;109(1):47-52. doi: 10.1002/jso.23457. Epub 2013 Oct 10.
4
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.
J Clin Oncol. 2010 Apr 1;28(10):1638-44. doi: 10.1200/JCO.2009.25.8376. Epub 2010 Mar 1.
5
Treatment strategy for locally recurrent rectal cancer.
Jpn J Clin Oncol. 2006 Mar;36(3):127-31. doi: 10.1093/jjco/hyi247.
Zotero 插件